Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15369390rdf:typepubmed:Citationlld:pubmed
pubmed-article:15369390lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:15369390lifeskim:mentionsumls-concept:C0019587lld:lifeskim
pubmed-article:15369390lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:15369390lifeskim:mentionsumls-concept:C1412431lld:lifeskim
pubmed-article:15369390lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:15369390lifeskim:mentionsumls-concept:C1710236lld:lifeskim
pubmed-article:15369390lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:15369390lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:15369390lifeskim:mentionsumls-concept:C1513371lld:lifeskim
pubmed-article:15369390pubmed:issue20lld:pubmed
pubmed-article:15369390pubmed:dateCreated2004-9-16lld:pubmed
pubmed-article:15369390pubmed:abstractTextWe previously reported that substrates of semicarbazide-sensitive amine oxidase in combination with low concentrations of vanadate exert potent insulin-like effects. Here we performed homology modeling of the catalytic domain of mouse SSAO/VAP-1 and searched through chemical databases to identify novel SSAO substrates. The modeling of the catalytic domain revealed that aromatic residues Tyr384, Phe389, and Tyr394 define a pocket of stable size that may participate in the binding of apolar substrates. We identified a number of amines as substrates of human, rat, and mouse SSAO. The compounds PD0119035, 2,3-dimethoxy-benzylamine, and C-naphthalen-1-yl-methylamine showed high affinity as substrates of rat SSAO. C-Naphthalen-1-yl-methylamine was the only substrate that showed high affinity for human SSAO. C-Naphthalen-1-yl-methylamine and 4-aminomethyl-benzenesulfonamide showed the highest capacity to stimulate glucose transport in isolated rat adipocytes. The impact of these findings on the development of new treatments for diabetes is discussed.lld:pubmed
pubmed-article:15369390pubmed:languageenglld:pubmed
pubmed-article:15369390pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15369390pubmed:citationSubsetIMlld:pubmed
pubmed-article:15369390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15369390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15369390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15369390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15369390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15369390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15369390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15369390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15369390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15369390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15369390pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15369390pubmed:statusMEDLINElld:pubmed
pubmed-article:15369390pubmed:monthSeplld:pubmed
pubmed-article:15369390pubmed:issn0022-2623lld:pubmed
pubmed-article:15369390pubmed:authorpubmed-author:OrozcoModesto...lld:pubmed
pubmed-article:15369390pubmed:authorpubmed-author:UnzetaMercede...lld:pubmed
pubmed-article:15369390pubmed:authorpubmed-author:De La...lld:pubmed
pubmed-article:15369390pubmed:authorpubmed-author:PalacínManuel...lld:pubmed
pubmed-article:15369390pubmed:authorpubmed-author:ZorzanoAntoni...lld:pubmed
pubmed-article:15369390pubmed:authorpubmed-author:MartiLucLlld:pubmed
pubmed-article:15369390pubmed:authorpubmed-author:TestarXavierXlld:pubmed
pubmed-article:15369390pubmed:authorpubmed-author:CarpénéChrist...lld:pubmed
pubmed-article:15369390pubmed:authorpubmed-author:AbellaAnnaAlld:pubmed
pubmed-article:15369390pubmed:authorpubmed-author:García-Vicent...lld:pubmed
pubmed-article:15369390pubmed:issnTypePrintlld:pubmed
pubmed-article:15369390pubmed:day23lld:pubmed
pubmed-article:15369390pubmed:volume47lld:pubmed
pubmed-article:15369390pubmed:ownerNLMlld:pubmed
pubmed-article:15369390pubmed:authorsCompleteYlld:pubmed
pubmed-article:15369390pubmed:pagination4865-74lld:pubmed
pubmed-article:15369390pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:meshHeadingpubmed-meshheading:15369390...lld:pubmed
pubmed-article:15369390pubmed:year2004lld:pubmed
pubmed-article:15369390pubmed:articleTitleExploring the binding mode of semicarbazide-sensitive amine oxidase/VAP-1: identification of novel substrates with insulin-like activity.lld:pubmed
pubmed-article:15369390pubmed:affiliationParc Científic de Barcelona and Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Avda. Diagonal 645, E-08028 Barcelona, Spain.lld:pubmed
pubmed-article:15369390pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15369390pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:15369390lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15369390lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15369390lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15369390lld:pubmed